Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Aggarwal

Showing results (131-140 of 262) with videos related to

Pageof 27
Sort By:
Frontiers in Immunology|June 19, 2024
Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndromeKoichi Yamaguchi, Qi Tang, Paul Poland, et al.
The Journal of Rheumatology|April 17, 2009
Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosusRohit Aggarwal, Caitlyn T Wilke, A Simon Pickard, et al.
Clinical Rheumatology|August 26, 2024
Internet-based enrollment of a myositis patient cohort-a national experienceRaisa Lomanto Silva, Shiri Keret, Tanya Chandra, et al.
Eclinicalmedicine|October 6, 2023
Efficacy of intravenous immunoglobulins (IVIg) in improving skin symptoms in patients with dermatomyositis: a post-hoc analysis of the ProDERM studyVictoria P Werth, Rohit Aggarwal, Christina Charles-Schoeman, et al.
Nature Reviews. Rheumatology|April 14, 2018
Update on outcome assessment in myositisLisa G Rider, Rohit Aggarwal, Pedro M Machado, et al.
Seminars in Arthritis and Rheumatism|June 24, 2022
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysisHaig Pakhchanian, Hiba Khan, Rahul Raiker, et al.
Rheumatology (Oxford, England)|January 14, 2017
Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosisRohit Aggarwal, Christine McBurney, Frank Schneider, et al.
Rheumatology (Oxford, England)|November 21, 2013
Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validationRohit Aggarwal, Chester V Oddis, Danielle Goudeau, et al.
Arthritis Care & Research|February 12, 2011
Serum free light chains as biomarkers for systemic lupus erythematosus disease activityRohit Aggarwal, Winston Sequeira, Rediet Kokebie, et al.
Rheumatology (Oxford, England)|March 12, 2020
Follow-up results of myositis patients treated with H. P. Acthar gelDidem Saygin, Chester V Oddis, Galina Marder, et al.
Pageof 27

Showing results (131-140 of 262) with videos related to

Sort By:
Pageof 27
Frontiers in Immunology|June 19, 2024
Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndromeKoichi Yamaguchi, Qi Tang, Paul Poland, et al.
The Journal of Rheumatology|April 17, 2009
Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosusRohit Aggarwal, Caitlyn T Wilke, A Simon Pickard, et al.
Clinical Rheumatology|August 26, 2024
Internet-based enrollment of a myositis patient cohort-a national experienceRaisa Lomanto Silva, Shiri Keret, Tanya Chandra, et al.
Eclinicalmedicine|October 6, 2023
Efficacy of intravenous immunoglobulins (IVIg) in improving skin symptoms in patients with dermatomyositis: a post-hoc analysis of the ProDERM studyVictoria P Werth, Rohit Aggarwal, Christina Charles-Schoeman, et al.
Nature Reviews. Rheumatology|April 14, 2018
Update on outcome assessment in myositisLisa G Rider, Rohit Aggarwal, Pedro M Machado, et al.
Seminars in Arthritis and Rheumatism|June 24, 2022
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysisHaig Pakhchanian, Hiba Khan, Rahul Raiker, et al.
Rheumatology (Oxford, England)|January 14, 2017
Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosisRohit Aggarwal, Christine McBurney, Frank Schneider, et al.
Rheumatology (Oxford, England)|November 21, 2013
Anti-transcription intermediary factor 1-gamma autoantibody ELISA development and validationRohit Aggarwal, Chester V Oddis, Danielle Goudeau, et al.
Arthritis Care & Research|February 12, 2011
Serum free light chains as biomarkers for systemic lupus erythematosus disease activityRohit Aggarwal, Winston Sequeira, Rediet Kokebie, et al.
Rheumatology (Oxford, England)|March 12, 2020
Follow-up results of myositis patients treated with H. P. Acthar gelDidem Saygin, Chester V Oddis, Galina Marder, et al.
Pageof 27